Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 18 di 18
Titolo Data di pubblicazione Autori Tipo File Abstract
Hemostasis in pregnant women with COVID-19 2020 Ciavarella A.Erra R.Mosca F.Ferrazzi E.Peyvandi F. + Article (author) -
Risk factors for mortality in hospitalized patients with COVID-19: a study in Milan, Italy 2020 Abbattista, MariaCiavarella, AlessandroCapecchi, MarcoGramegna, AndreaLombardi, RosaScaramellini, NataliaPeyvandi, Flora + Article (author) -
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19 2021 Ciavarella A.Abbattista M.Aliberti S.De Zan V.Gori A.Artoni A.Carrafiello G.Grasselli G.Blasi F.Peyvandi F. + Article (author) -
Real‐world data on emicizumab prophylaxis in the Milan cohort 2022 Arcudi, SaraGualtierotti, RobertaMarino, SoniaCiavarella, AlessandroBoscarino, MarcoPeyvandi, Flora + Article (author) -
Updates on Novel Non-Replacement Drugs for Hemophilia 2022 Gualtierotti R.Ciavarella A.Arcudi S.Giachi A.Garagiola I.Suffritti C.Siboni S. M.Peyvandi F. + Article (author) -
Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination 2022 Roberta GualtierottiSara ArcudiAlessandro CiavarellaFlora Peyvandi + Article (author) -
Anticoagulant Therapy in Patients with Antiphospholipid Syndrome 2022 Ciavarella A. + Article (author) -
Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study 2023 Roberta GualtierottiAlessandro CiavarellaFlora Peyvandi + Article (author) -
Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy 2023 Vincenzo La MuraNiccolò BittoCamilla CaputoAlessandro CiavarellaRoberta GualtierottiAnna Ludovica FracanzaniFlora Peyvandi + Article (author) -
Hemorrhagic and thrombotic adverse events associated with emicizumab and extended half-life factor VIII replacement drugs: EudraVigilance data of 2021 2023 Abbattista, MariaCiavarella, AlessandroPeyvandi, Flora + Article (author) -
A retrospective study on the use of low-molecular-weight heparin for prevention of pregnancy-related recurrent venous thromboembolism and obstetrical complications 2023 Capecchi, MarcoGianniello, FrancescaBucciarelli, PaoloCiavarella, AlessandroPeyvandi, Flora + Article (author) -
Anti-emicizumab antibodies do not cross-react with mim8 in vitro 2023 Valsecchi, CarlaGualtierotti, RobertaArcudi, SaraCiavarella, AlessandroSiboni, Simona MariaPeyvandi, Flora + Article (author) -
Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome 2024 Agosti P.Siboni S. M.Ciavarella A.Arcudi S.Boggio F.Gualtierotti R.Peyvandi F. Article (author) -
Assessing joint health in haemophilia patients: The combined value of physical examination and ultrasound imaging 2024 Gualtierotti, RobertaGiachi, AndreaTruma, AddolorataArcudi, SaraCiavarella, AlessandroBucciarelli, PaoloSiboni, Simona MariaPeyvandi, Flora + Article (author) -
Ultrasound evaluation of hemophilic arthropathy: a proposal of definitions in a changing landscape 2024 Gualtierotti, RobertaPeyvandi, FloraGiachi, AndreaCiavarella, Alessandro + Article (author) -
Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWF 2024 Seidizadeh, OmidCiavarella, AlessandroBoggio, FedericoBallardini, FrancescoPagliari, Maria TeresaPeyvandi, Flora + Article (author) -
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A 2024 Seidizadeh, OmidMollica, LucaBaronciani, LucianoPagliari, Maria TeresaCiavarella, AlessandroSiboni, Simona M.Peyvandi, Flora + Article (author) -
Variant p.Tyr1584Cys: a frequent von Willebrand factor variant in search of von Willebrand disease 2024 Seidizadeh, OmidBaronciani, LucianoCiavarella, AlessandroSiboni, Simona MariaPeyvandi, Flora + Article (author) -
Mostrati risultati da 1 a 18 di 18
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile